# Jasper Therapeutics, Inc.: Form 8-K, filed Jul 9, 2025

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2025-07-09
- Accepted by EDGAR: Jul 9, 2025, 08:05 ET
- Period: 2025-07-08
- Accession: 0001213900-25-062194
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390025062194/ea0248394-8k_jasper.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390025062194/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390025062194/ea0248394-8k_jasper.htm

Filed Jul 9, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-062194. Last ingested by Listed: Nov 4, 2026, 08:12 ET. No prices; not investment advice.